Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DUAO82
|
|||
| Drug Name |
Evt201
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Sleep-wake disorder [ICD-11: 7A00-7B2Z] | Phase 2 | [1] | |
| Company |
Evotec
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GABA(A) receptor (GABAR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00380003) Efficacy Study of EVT 201 to Treat Insomnia. U.S. National Institutes of Health. | |||
| REF 2 | The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients. Sleep Med. 2009 Sep;10(8):859-64. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.